Dyne Therapeutics Inc

Market Cap

$3B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$16.81-$1.69 (-9.14%)

Jun 8, 2026

52W High $24.2952W Low $8.18

Company Details

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutic...

CEO

—

IPO Date

Sep 17, 2020

Website

www.dyne-tx.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$452M

EPS (Diluted)

Free Cash Flow

-$462M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Jul 27, 2026

PENDING

Q1 2026

May 11, 2026

FY 2025

Mar 2, 2026

Q4 2025

Mar 2, 2026

$0-100.0%

Q3 2025

Nov 5, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee